Partner Content Partner Content Program to Discuss eRegulatory Submission Processes and Prot... Summit will explore the electronic submission process and protocols for IDMP, RIM, global, and regulatory submissions.
News More good news in Sjogren's as RemeGen trial delivers A second new drug, RemeGen's telitacicept, has shown efficacy in a phase 3 Sjögren's syndrome trial in the space of a week.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
